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Abstract
The Centers for Disease Control and Prevention’s Screen for Life: National Colorectal Cancer 
Action Campaign (SFL) is one of the longest running national multimedia campaigns to promote 
colorectal cancer screening. Since its inception in 1999, no study has quantified the benefits and 
costs of SFL. We modeled the impact of SFL campaign on screening rates, assuming that the 
effect size would range from 0.5% to 10% of the unscreened population exposed to the campaign 
in the last 14 years. Given the estimated benefits of the campaign and costs, we calculated the cost 
per person screened (2012 dollars). We hypothesize that if 0.5% of the population exposed to 
campaign messages were screened for colorectal cancer, an additional 251,000 previously 
unscreened individuals would be screened. The average cost of SFL per person screened would be 
$2.44. On the other hand, if 10% of the population exposed to campaign messages were screened, 
an additional 5.01 million individuals would be screened. The average cost per person screened 
would be $0.12. Results indicate that SFL improves screening rates at a relatively low cost per 
person screened. The findings in this study provide an important starting point and benchmark for 
future research efforts to determine the benefits and costs of health communication campaigns to 
promote cancer prevention.
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INTRODUCTION
Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States 
among cancers that affect both men and women and the third most commonly diagnosed 
cancer in adults aged 50 years and older (U.S. Cancer Statistics Working Group, 2009). Each 
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year, more than 135,000 people are diagnosed with CRC and more than 51,000 die from this 
cancer (U.S. Cancer Statistics Working Group 2009). Despite strong scientific evidence that 
CRC screening reduces the burden of illness and recommendations from the U.S. Preventive 
Services Task Force (USPSTF; 2011) that adults ages 50 to 75 years receive regular 
screening tests, screening rates remain low. In recent studies, CRC screening rates are 
estimated to range from 54.5% to 65.4% (Centers for Disease Control and Prevention 
[CDC], 2011; Shapiro et al., 2012) and lag behind screening rates for breast and cervical 
cancers, which are 72.4% and 83.0%, respectively (CDC, 2010). The federal government has 
undertaken a number of initiatives to promote CRC screening (Colorectal Cancer Control 
Program). Recently, the CDC launched a population-based Colorectal Cancer Control 
Program (http://www.cdc.gov/cancer/crccp/index.htm) designed to provide screening and 
promote activities to increase CRC screening rates in the population. In 2000, the U.S. 
Congress designated March as “National Colorectal Cancer Awareness Month” to increase 
public awareness about the disease and encourage CRC screening among persons 50 years 
and older. This followed the March 1999 launch of CDC’s Screen for Life: National 
Colorectal Cancer Action Campaign (SFL), a multimedia initiative to increase knowledge 
and promote CRC screening (CDC, 2012).
Since the launch of the SFL campaign, studies have reported on the development, 
implementation, and dissemination of campaign materials to target populations (Cooper et 
al., 2005; Jorgensen, Gelb, Merritt, & Seeff, 2001; Lengerich, Rubio, Brown, Knight, & 
Wyatt, 2012; Vanderpool & Coyne, 2006; Ward, Coffey, Lengerich, & Piccinin, 2006). 
During this period, no study has quantified the potential benefits and costs of the campaign 
in reaching and encouraging target populations to be screened. The cost of cancer screening 
promotion activities have rarely been factored into estimates of the effectiveness or cost-
effectiveness of screening programs. Omission of promotional costs in the estimation of 
cost-effectiveness of CRC screening may provide an incomplete account of resources 
expended on CRC screening and potentially may result in the underestimation of 
intervention costs. The purpose of this study was to quantify the potential benefits and costs 
associated with screening uptake among eligible U.S. adults resulting from exposure to SFL 
campaign messages.
MATERIALS
Overview of the SFL Campaign
SFL is a national multimedia campaign that was developed by the CDC and launched in 
March 1999 by the U.S. Department of Health and Human Services (CDC, 2012). The goals 
were to (a) promote CRC screening, (b) inform and educate men and women 50 years and 
older about the importance of having regular CRC screening tests as recommended by the 
USPSTF (2011), and (c) communicate how CRC screening saves lives through early 
detection of cancer and by finding precancerous polyps that can be removed before they 
become cancerous (Rex, Johnson, Lieberman, Burt, & Sonnenberg, 2000).
The campaign is based on extensive research, including over 200 focus groups in more than 
30 cities across the United States. The SFL uses social cognitive theory and the theory of 
planned behavior as the primary foundation to guide both the development and evaluation of 
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activities (Glanz, Lewis, & Rimer, 1997). Furthermore, other aspects of the study such as 
cancer screening and economic costs are supported by strong theoretical foundations (Eddy, 
1980; Gold, Siegel, Russel, & Weinstein, 1996). Since the campaign’s launch, its messages 
have been included in a wide variety of materials, including brochures, fact sheets, posters, 
broadcast and print public service announcements (PSAs), digital media, and out-of-home 
advertising. The TV PSAs are distributed to more than 1,000 TV stations in all 210 U.S. 
designated media markets, including national networks and regional cable systems. The 
radio PSAs are distributed nationwide to nearly 1,200 radio stations. The print PSAs are 
distributed to nearly 2,000 magazines and 6,000 daily and weekly newspapers nationwide. 
The campaign’s out-of-home displays are available in many public places, such as airport 
and shopping mall dioramas; as advertisements in transit stations; on trains and buses; in 
transit shelters; in elevator video monitors; and other venues. The campaign also maintains a 
robust website and a presence on social media channels such as Facebook and YouTube.1 To 
further maximize exposure and increase awareness of CRC screening to the target 
population, the campaign includes professional actors, actresses, and well-known public 
figures (e.g., a news-woman and a former U.S. Surgeon General) as spokes-persons in PSAs. 
Most campaign materials are available in both English and Spanish.
Measuring Impact and Estimating Population Screened Through Exposure to the SFL 
Campaign
According to previous studies of the impact of mass media campaigns (Cram et al., 2003; 
Hornik, 2002; Myhre & Flora, 2000; Randolph & Viswanath, 2004; Sequist, Franz, & 
Ayanian, 2010; Snyder, 2007; Snyder & Hamilton, 2002), the necessary conditions for 
successful public health preventive campaigns to have substantial effects in the target 
population are (a) widespread dissemination of campaign materials, (b) high saturation 
through constant PSAs, (c) novel placement spots and diversity of PSAs to different 
subgroups of the target population, (d) endurance of the campaign to ensure that the 
exposure time is long enough to change people’s behavior, and (e) having a celebrity and/or 
public figure spokesperson for the campaign. The SFL campaign meets all these criteria. 
Because we were unable to estimate the impact of SFL directly, we modeled the impact of 
the campaign using a range of effect sizes obtained from prior studies of the impact of public 
health media campaigns (Cram et al., 2003; Sequist et al., 2010; Snyder, 2007). We assumed 
that the effect size (i.e., the proportion of the target population exposed to the campaign who 
are screened as a direct result of the campaign) would range from a minimum of 0.5% to a 
maximum of 10% (Cram et al., 2003; Sequist et al., 2010; Snyder, 2007) of unscreened 
persons exposed to the campaign in the past 14 years (i.e., 1999–2012). Using the assumed 
effect size and other data obtained from the literature, we estimated the benefits of SFL 
defined as the incremental population screened resulting from exposure to campaign 
messages.
1Use of trade names is for identification purposes only and does not imply endorsement by the authors, the CDC, or the U.S. 
Department of Health and Human Services.
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Estimating Intermediate Outcome of the Campaign Measured by Incremental Population 
Screened
We estimated the number of persons who did not receive a CRC screening test over the 
period 1999 to 2012 based on (a) the total average U.S. population age 50 to 80 years from 
1999 to 2012, which was about 86 million (U.S. Census Bureau, Population Division, 2012), 
(b) the proportion of the population that is already adhering to CRC screening 
recommendations, which was reported to be 58.3% (range: 50.0% to 70%; Shapiro et al., 
2012); and (c) the proportion of the population that has already received a CRC screening 
test. We assume that 60% (range: 54.5% to 65.4%) of persons in the target age range were 
screened and the remainder were unscreened (CDC, 2011; Shapiro et al., 2012). We 
estimated the impact of the SFL campaign on the number of persons screened by applying 
the effect size, 0.5% to 10%, to the baseline estimate of the unscreened population.
Estimating Cost per Person Screened Due to the SFL Campaign
We estimated the cost per person screened based on the total cost of the campaign from 1999 
to 2012. Total costs include the direct cost and the value of in-kind services donated to the 
campaign. The direct costs include costs incurred in developing and testing campaign 
messages and creative approaches for all TV, radio, video, and print PSAs. It includes costs 
for developing out-of-home displays and patient materials such as posters, fact sheets, 
brochures, and airport dioramas. The direct cost of the campaign also includes costs for 
professional consultation, formative research activities, travel to and from study sites, 
supplies, and other consumables.
The indirect cost category includes the value of time for public figures who donated their 
services as spokes-persons and are featured in the campaign PSAs and the value of time and 
placements donated to the campaign by local, regional, and national media outlets for PSAs 
and out-of-home displays. To measure the value of these in-kind donated services, we used 
the equivalent market value reported for each element of the campaign. The equivalent 
market value was obtained from the campaign administrator at CDC and was defined as the 
amount of money CDC would have paid to hire celebrity spokespersons and purchase 
airtime and space if these campaign-related advertising placements were not donated. This 
approach provides an accurate estimate of the total campaign cost and is recommended by 
the U.S. Panel on Cost-Effectiveness (Gold et al., 1996).
We adjusted costs to 2012 U.S. dollars using the all-item consumer price index (U.S. Bureau 
of Labor Statistics, 2012). We estimated the cost per person exposed to campaign messages 
at any time during the past 14 years, for various levels of the campaign’s effect size.
RESULTS
If 0.5% of the target population exposed to campaign messages were screened as a result of 
the exposure, an additional 251,000 persons would have been screened over the period 
1999–2012. If the effect size was 10%, an additional 5.01 million persons would have 
received screening during this time period as a result of the campaign.
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Figure 1 presents the adjusted and unadjusted direct cost of the campaign over 14 years. The 
total direct cost of SFL was $14.48 million (2012 dollars), or $1.03 million per year, with a 
standard deviation (SD) of $0.36 million. These costs varied considerably from year to year.
The total value of in-kind donated services to the campaign was $147.78 million, with an 
average of $10.56 million and an SD of $6.73 million (Table 1). The value of in-kind 
donated services represented 86% of the total cost of the campaign. As mentioned earlier, in-
kind donated services to the campaign include a broad variety of media channels. Among 
these channels, the total value of donated TV airtime was the highest, estimated to be $86.56 
million, with an annual average cost of $6.18 million and an SD of $2.72 million. The total 
value of donated patient educational materials was the lowest, estimated to be $12.18 
million, with an annual average cost was $0.87 million and an SD of $1.23 million (Table 1).
Based on the adjusted direct cost of the campaign, the average annual cost per person 
screened was estimated to be $2.44 (SD of $0.90) when the campaign effect size was 0.5% 
(Table 2). The estimated average annual cost per person screened was only $0.24 (SD of 
$0.09) and $0.12 (SD of $0.04) when the campaign effect size was 5% and 10%, 
respectively. In Table 2 we also present the median cost per person screened, the associated 
interquartile range, and the average annual cost per person screened using both the direct 
cost and the cost of in-kind donated services. As expected, the average annual cost per 
person screened using the combined costs was substantially higher compared with the direct 
cost alone.
The estimated average annual cost per person screened for different values of the CRC 
screening compliance rate (50% and 70%) are presented in Figures 2A and B, respectively. 
When the compliance rate was 50% (the lowest rate) and the campaign effect size was 0.5% 
(also the lower rate), the estimated direct cost per person screened was $2.09. The direct and 
indirect cost per person screened was $22.79 (Figure 2A). Conversely, when the compliance 
rate was low and the effect size was high (10%), the estimated direct cost per person 
screened was $0.10. When the compliance rate was 70% (the higher rate) and the campaign 
effect size was 0.5% (the lower rate), the estimated direct cost per person screened was 
$22.33. When the compliance rate was high and the effect size was also high, the estimated 
direct cost per person screened was $1.12 (Figure 2B).
DISCUSSION
Under reasonable assumptions about the effectiveness of the SFL campaign, we estimate 
that the direct cost per additional person screened was $0.12 to $2.44. These figures 
represent 0.02% to 0.5% of the cost of a colonoscopy to the Medicare program 
(approximately $500; Zauber 2010). On average, persons screened via colonoscopy gain an 
extra 0.1 life years at a cost of $690 in direct medical costs (Zauber, 2010). Assuming that 
the cost per additional person screened is $2.44, then the cost per life year gained of the SFL 
program is $6,924 ([$690 + $2.44] ÷ 0.1). This calculation assumes that there are people 
who would not have been screened in the absence of the SFL campaign. For a “price” of 
$2.44, these persons received a service that costs $690 and provides 0.1 life year. The cost 
per life year gained is well below thresholds typically used to assess whether services are 
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cost-effective. We have chosen to illustrate cost-effectiveness using cost and effectiveness 
figures for colonoscopy because it is one of the most commonly used CRC screening 
modalities in the United States. However, many other commonly used screening tests are at 
least as cost-effective as colonoscopy (Zauber, 2010).
The SFL campaign is one of the longest running national health communication campaigns 
to promote CRC. Because of its longevity, it is difficult to estimate its impact on screening 
rates because there are so many other factors that could have accounted for increases in 
screening rates since its inception. Unfortunately, most mass media campaigns to promote 
cancer screening are not subject to rigorous evaluation (Sabatino et al., 2012). Going 
forward, it is important that newly initiated health promotion campaigns are designed with 
more comprehensive evaluation components. Given the lack of estimates of the direct impact 
of the SFL, we were very cautious in estimating the potential benefits. The results presented 
in this article will be useful for planning health communication campaigns to promote 
colorectal and other cancers.
The SFL campaign is part of a coordinated effort by the CDC to use evidence-based 
interventions to help reduce the burden of CRC in the population. These efforts include the 
CDC’s Colorectal Cancer Control Program and applied research to identify effective 
methods to increase the use of CRC screening services (http://www.cdc.gov/cancer/crccp/
index.htm). Each of these and other efforts have used SFL campaign materials tailored to 
specific local partners to support public education and outreach. This collaborative work 
between SFL and other CDC CRC-related initiatives creates synergy and perhaps reduces 
the initial cost of providing public education and outreach campaigns to these initiatives.
Donated services were 86% of the total cost of the campaign. This is not surprising. Many 
public health communication campaigns depend on donations from media outlets for PSAs 
(Rideout & Hoff, 2002). Unfortunately, reliance on donated airtime for PSAs often results in 
campaign messages being played during less optimal time slots, leading to limited message 
exposure to the intended audience (Gantz, Schwartz, & Angelini, 2008; Rideout & Hoff, 
2002). Sponsors of health communication campaigns such as CDC’s SFL are aware of this 
limitation and have supplemented the donated PSA messages with Internet and “small 
media” strategies that included distribution of printed materials such as posters, brochures, 
fact sheets, and videos featuring personal testimony from actors and actresses. SFL also 
works closely with its partners in health departments in all 50 states, two tribal 
organizations, and the District of Columbia to provide localized options for PSAs and 
printed educational materials.
This study has some limitations. The reported incremental benefits and costs of the 
campaign were not separated by different CRC screening tests. We do not have outcome 
measures of the campaign and do not want to speculate on the potential effectiveness of the 
campaign on the use of different CRC screening tests. Our inability to separately estimate 
the impact of SFL on the use of different types of screening tests does not substantially 
affect the usefulness of our results because it is well documented that all screening 
modalities are effective in reducing CRC mortality (Hardcastle et al., 1996; Kronborg, 
Fenger, Olsen, Jorgensen, & Sondergaard, 1996; Mandel et al., 1993). The effectiveness data 
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used were obtained from population-based CRC screening activities (Cram et al., 2003; 
Sequist et al., 2010) and from meta-analysis and research syntheses conducted in the past 
two decades which examined the effectiveness of communication campaigns (Snyder, 2007). 
In light of the results from this literature, our assumptions represent a reasonable range of 
effect sizes.
Future Directions in the Economics of Health Communication Campaigns to Promote 
Cancer Screening
According to the Community Preventive Services Task Force (2012), there are no economic 
studies conducted to date to ascertain the cost-effectiveness of health communication 
campaigns in promoting cancer screening. Economic analysis can provide a valuable 
contribution to the field of health communication by estimating the cost and cost-
effectiveness of different components of social media campaigns used in promoting cancer 
prevention. Given the rapidly changing media landscape in health communication 
technology, this is an important area of future research. Today, many health communication 
campaigns use different social media strategies to reach their intended audience. However, 
little information is available on the cost-effectiveness of these social media campaigns in 
changing behavior for primary and secondary prevention of cancer.
CONCLUSIONS
Most health communication campaigns, particularly those in cancer prevention and control, 
have very low budgets to cover their campaign activities. However, these health 
communication campaigns need to demonstrate effectiveness and accountability to patients, 
taxpayers, and other stakeholders. In this study, we demonstrated how economic analysis can 
be used to assess health communication campaigns if effectiveness and cost data from these 
campaigns are available. Our results suggest that the SFL campaign may have contributed to 
improving CRC screening rates at a minimal cost. The findings in this study provide an 
important starting point and benchmark for future evaluation research efforts to determine 
the benefits and costs of health communication campaigns to promote cancer prevention.
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FIGURE 1. 
Trends in the Costs of the Screen for Life Campaign 1999–2012
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FIGURE 2. 
(A) Estimated Average Annual Cost per Person Screened Due to Screen for Life Campaign 
by Different Values of Effect Size When the Compliance of Colorectal Cancer Screening 
Rates Was 50.0% (Lower Value); (B) Estimated Average Annual Cost per Person Screened 
Due to Screen for Life Campaign by Different Values of Effect Size When the Compliance 
of Colorectal Cancer Screening Rates Was 70.0% (Higher Value)
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